The Relationship Between the Residual Renal Function and Osteoporosis Treatment
NCT02304887
·
clinicaltrials.gov ↗
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Bis, SERM Teriparatide, Denosumab
Sponsor
Toshihiko Kono